Viewing Study NCT03381066


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-01-03 @ 11:08 PM
Study NCT ID: NCT03381066
Status: UNKNOWN
Last Update Posted: 2019-01-11
First Post: 2017-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III, Randomized, Multi-center Study to Determine the Efficacy of the Intercalating Combination Treatment of Chemotherapy and Gefitinib or Chemotherapy as Adjuvant Treatment in NSCLC With Common EGFR Mutations.
Sponsor: Yonsei University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Completely Resected NSCLC With Common EGFR Mutations View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None EGFR View
None adjuvant View
None gefitinib View
None intercalating View